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Purpose: to report surgical and corneal clarity scores (CCSs) of corneo-limbo-conjunctival 
transpositions (CLCTs) in a large number of canine cases.  
Methods: retrospective review of records that underwent CLCT to repair deep ulcers or 
perforations between 2002-2018. Signalment, concurrent eye disease, additional procedures, 
pathogenesis, medication, graft orientation, follow-up and CCSs were recorded.  
Results: 418 eyes of 399 dogs were included. Brachycephalics were most commonly 
affected, comprising 325/418 (77.75%) of the eyes. The most commonly affected breeds were 
Pugs, Shih-Tzus, Cavalier King Charles Spaniels and French Bulldogs, with 116/418 
(27.75%), 64/418 (15.31%), 34/418 (8.13%), and 34/418 (8.13%) ulcerated eyes, 
respectively. Mean age at surgery was 5.5 years (range 59 days – 17.7 years) and median 
follow-up time was 100 days (range 3 days - 7.64 years). The most common etiopathogenesis 
was spontaneous ulceration in 205/418 eyes (49.04%) of which 191 (93.17%) occurred in 
brachycephalics. Primary keratoconjunctivitis sicca affected 122/418 eyes (29.19%) and 
injury 39/418 eyes (9.33%). Mean ulcer width was 3.5 mm (0.5-10 mm). Success rate was 
97.13% (406/418 eyes). Failure endpoints recorded included no menace response, secondary 
glaucoma and endophthalmitis. Pre-existing perforation was found in 101/418 (24.16%) of 
the eyes and significantly increased failure rate (p<0.001). The median CCS was G3 (G0-G4), 
which was lower for Pugs (G2). Graft orientation affected CCS, but did not reach statistical 
significance.  
Conclusion: The high success rate and CCS for CLCT in dogs make it a good technique to 










Ulcerative keratitis is a common and widely varied ocular disease in the dog.1–9 The facial 
characteristics of brachycephalics and some spaniels have long been suspected to play a role 
in the development of deep corneal ulcers associated with KCS.4 Recently, a large population 
study reported that brachycephalic and spaniel-type dogs with prominent eyes have a general 
increased susceptibility to corneal ulceration.10 Surgical repair of corneal ulcers is 
recommended in cases where corneal stromal loss is greater than 50% of corneal depth.2 A 
common form of surgical repair is corneal reconstruction through grafting, which aims to 
preserve the eye and corneal clarity where possible.1,2 Multiple corneal reconstructive 
techniques have been described utilizing conjunctiva, amniotic membrane, corneal tissue and 
synthetic or bioengineered materials.3–21. The use of lamellar corneal grafting techniques can 
better preserve corneal transparency when compared to conjunctival pedicle grafting. 18,22–26 
Autologous grafts offer the advantage that they avoid immune mediated graft rejection and 
the need for corneal banking. 6,18,22 Lamellar corneo-scleral transplantation (CST) is an 
autologous graft technique that uses cornea and the adjacent sclera.18 A modification of this 
technique is corneal-scleral-conjunctival transposition (CSCT), which uses a sliding graft of 
peripheral cornea, limbus and bulbar conjunctiva. 22,23 Other surgeons refer to this technique 
as corneo-conjunctival transposition (CCT)24–26, while others refer to it as corneo-limbo-
conjunctival transposition (CLCT)27 to highlight the inclusion of the limbus. The authors of 
the present study have used the term CLCT. 
Two separate reviews of CLCTs in cats reported surgical success rates of 100% and 94.8% in 
series of 17 and 97 patients respectively. 24,25 The studies in felines focused on the repair of 
corneas affected by corneal sequestrum and this is a disease that is extremely rare in dogs, as 
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suggested by the very low number of affected dogs in the veterinary literature.28,29 Taking this 
into consideration in addition to potential interspecies differences that might affect corneal 
healing, studies that focus on CLCTs in dogs are warranted. Comparatively speaking, there 
have been very few reports on the use of CLCTs in canines including a preliminary report of 
canine cases with deep corneal ulcers that suggested the technique deserved further study in 
this species.27 The first published series on the use of CLCT in dogs supported the use of this 
technique.26 It also concluded that further evidence on the outcome of a larger number of 
cases and the use of an objective assessment of corneal clarity were needed.26  
The main objectives of the present study are to report the surgical outcome of a large number 
of CLCTs in dogs and the resulting corneal clarity scores (CCSs) using a validated corneal 
clarity scoring scale 1 in a large proportion of these cases.   
 
2. MATERIAL AND METHODS 
2.1 Animals and inclusion criteria 
The authors performed a retrospective review of the medical records of dogs that underwent a 
CLCT by a variety of surgeons to repair deep corneal ulcers (i.e. ≥50% depth) and 
perforations between 2002 and 2018 at the following centers: Optivet Referrals (Havant, UK), 
North Kent Referrals (Kent, UK), Royal Veterinary College (Hatfield, UK) and 
Specialistische Dierenkliniek Utrecht, (Utrecht, NL). 
Inclusion criteria accepted animals with a complete ophthalmic examination prior to surgery 
that included Schirmer tear test I (Schering-Plough Animal Health Corporation, Union, NJ), 
menace response, palpebral, dazzle and pupillary light reflexes, slit lamp biomicroscopy 
(Kowa SL15 or SL17; Kowa Company, Ltd, Tokyo, Japan), rebound tonometry (TonoVet®; 
Tiolat, or Tono-pen Vet®; Icare, Finland), indirect ophthalmoscopy (Vantage Plus; Keeler or 
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Omega 500; Heine, Ettenheim, Germany) with a hand-held 30D lens (Volk Optical Inc, Ohio, 
USA) when not precluded by the corneal changes and fluorescein testing (Minims® 
Fluorescein sodium 1% w/v, Bausch & Lomb, UK).    
Data collected included signalment, cause of the ulcer, depth, eye affected, concurrent eye 
diseases, surgeon, additional procedures performed, medication before and after surgery, graft 
orientation, follow up time, outcome, complications, and CCS, when available. Only CCSs 
that were performed on the patient, as opposed to images, were included.  
Cases were excluded if patients underwent intraocular surgery (i.e. intracapsular lens 
extraction or phacoemulsification) at the same time of corneal repair.  
2.2 Pre-operative preparation 
Pre-medication was chosen for each patient based on their temperament and general health, 
including an opioid (methadone 0.1-0-3mg/kg IM/IV, Comfortan®, Dechra, UK) and/or 
acepromazine (0.005-0.1mg/kg IV/IM, Acepromazine, Elanco, UK) or dexmedetomidine 
(0.003-0.005mg/kg IV/IM, Dexdomitor®, Vetoquinol, UK). Following routine pre-
oxygenation, anaesthesia was induced with propofol (PropoFlo®Plus, Zoetis UK Limited) or 
alfaxalone (Alfaxan®, Jurox, UK) to effect. General anesthesia was maintained at an 
appropriate level with Isofluorane (IsoFlo®, Zoetis UK Ltd.), or sevofluorane (SevoFlo®, 
Zoetis UK Ltd.) in 100% oxygen after endotracheal intubation. Patients received an 
intravenous antibiotic during general anesthesia if indicated (cefuroxime, Zinacef®, Glaxo 
Smith Kline, UK, at 15mg/kg of body weight) and an injectable nonsteroidal anti-
inflammatory drug (carprofen, Rimadyl®, Zoetis UK limited, at 4mg/kg of body weight, or 
meloxicam, Metacam®, Boehringer Ingelheim Animal Health UK Ltd, at 0.1 mg/kg of body 




Patients were positioned under an operating microscope for the procedure, in dorsal or lateral 
recumbency, depending on the surgeon’s preference, and an intravenous neuromuscular 
blocking agent was administered IV (atracurium, Tracrium®, GlaxoSmithKline, UK) 
alongside mechanical ventilation and train of four monitoring. A single drop of topical 
anesthesia (Minims® Proxymetacaine hydrochloride 0.5% w/v, Bausch & Lomb, UK) was 
applied 1 minute prior to first corneal incision, when available. 
 
2.3 Surgical procedure  
All cases included underwent a CLCT graft in a similar manner. The walls of the corneal 
ulcer were debrided with the aid of the disposable controlled depth blade (Sharpoint® 300-
micron restricted depth knife, Pennsylvania, USA) and/or a diamond knife to remove any 
damaged stroma. Then, the ulcer was cut into a square in three of the four sides that make up 
this shape, purposely leaving the edge of the ulcer closest to the distal edge of corneal section 
of the graft to be cut later. Then, the path of the graft was cut into the tissue by extending the 
two parallel incisions on either side of the ulcer in the direction of the corneoscleral limbus 
until they went over it and into the adjacent conjunctiva. The surgeon made sure the sides of 
the graft diverged from one another so that the graft was approximately 0.5 to 1mm wider 
than the ulcer bed. Then, the corneal section of the graft was undermined at a depth of 
approximately half corneal thickness. This was achieved using a disposable lamellar 
dissection knife (Alcon® crescent knife angled bevel up, Texas, USA) starting at the side of 
the graft that offered the most comfortable position for the dominant hand of the surgeon. 
Care was taken to introduce the dissector knife at least 0.5mm under the entire limbal section 
of the graft to make sure the cutting edge of a scissor blade could be later introduced into it. 
When necessary and in order to completely free the corneal section of the graft, straight 
Vannas scissors were used to cut the incision line of the corneal section of the graft opposite 
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the one used as the entry point for the corneal lamellar dissector. Then, curved Westcott 
tenotomy scissors were used to undermine the conjunctival section of the graft. After this, one 
blade of the tenotomy scissor was introduced under the conjunctiva and the other under the 
limbus so the graft containing cornea, a section of limbus and conjunctiva could be freed from 
its limbal attachment. The entire graft was then lifted and transposed, which sometimes 
necessitated further subconjunctival dissection. The incomplete square cut around the ulcer 
permitted that a rim of ulcerated cornea remained attached to the distal end of the graft. This 
additional amount of corneal tissue served as a disposable grasping surface that helped 
manipulate the graft without risking traumatizing the rest of it. Once the graft was ready for 
suturing the rim of excess cornea was cut using the restricted depth blade, diamond knife 
and/or Vannas scissors. Some of the surgeons cut a complete square around the ulcer before 
extending the incision path in the direction of the corneoscleral limbus on either side of the 
ulcer. This meant there was no disposable grasping surface for graft handling later. The graft 
was secured to the recipient bed with monofilament 9-0 polyglactin 910 on a spatulated 
needle (Vicryl®, Johnson & Johnson Medical, UK) in all cases. All surgeons used a simple 
interrupted suture pattern while some surgeons also used a continuous suture pattern in parts 
of the graft or over the simple interrupted sutures. The first simple interrupted sutures were 
placed in the corneal section of the graft or in the limbal section of the graft followed by the 
corneal section of the graft. In either case, the conjunctival section was always sutured last. 
Depending on the surgeon, the first three sutures of the corneal section were placed either at 
the corners of the graft and then between them, or at the center between the corners, and then 
also at the corners. At the end, some surgeons rotated the simple interrupted suture knots into 
the suture tracks to bury the knots.  
 
2.4 Post-operative treatment 
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All the animals were prescribed a broad-spectrum antibiotic such as triple topical antibiotic 
combination drop containing neomycin sulphate 1700 IU/ml, polymixin B sulphate 5000 
IU/ml and gramycidin 25 IU/ml (Neosporin®, Dominion Pharma, England, UK), or 
chloramphenicol (Chloramphenicol 0.5% eye drops, Martindale Pharma, UK) or ofloxacin 
eye drops (Exocin® 0.3% eye drops, Allergan, Ireland) 3 to 4 times daily for approximately 2 
weeks. Depending on the degree of reflex uveitis and presence of concurrent KCS, a course of 
topical atropine sulfate 1% (Atropine Eye Drops, Martindale, England, UK or Minims® 
atropine sulfate 1% w/v, Bausch & Lomb, UK) or cyclopentolate (Minims® cyclopentolate 
hydrochloride 1% w/v , Bausch & Lomb, UK) was also prescribed for 1 to 10 days. A course 
of oral nonsteroidal anti-inflammatory (Carprofen, Rimadyl®, Zoetis UK limited, at 4mg/kg 
of body weight, or meloxicam, Metacam®, Boehringer Ingelheim Animal Health UK Ltd, at 
0.1 mg/kg of body weight) was prescribed once daily for 5-7 days in every case unless there 
was a contraindication. A one-week course of oral antibiotic (cephalosporine, Rilexine®, 
Virbac limited, at 15 mg/kg of body weight or amoxicillin-clavulanic acid, Synulox®, Zoetis 
UK limited, at 12.5 mg/kg of body weight) was prescribed in patients undergoing concurrent 
eyelid surgery and/or in perforated globes. All animals were fitted with a protective collar for 
1 to 2 weeks. Animals with KCS were prescribed cyclosporine 0.2% ointment (Optimmune®, 
Scherring Plough Animal Health, England, UK) once to twice daily, and a tear supplement, 
such as a carbomer 2mg/g containing viscous gel (Viscotears®, Novartis Pharmaceuticals, 
UK Ltd) or sodium hyaluronate based (Clinitas®, sodium hyaluronate 0.4%, Altacor, UK).  
Depending on surgeons´ preference, a 2 to 4-week course of topical steroid vs. non-steroidal 
eye drops and/or topical tacrolimus was dispensed 7-10 days after surgery in cases that 





Re-examinations were scheduled at approximately 1, 4, 8 and 12 or 16 weeks postoperatively 
with some cases having further visits if recommended for a variety of reasons such as re-
evaluation of KCS. 
 
2.6 End points: 
These included severe corneal opacification leading to a negative menace response, graft 
failure that despite surgical or medical treatment led to loss of vision or loss of the eye, and 
other postoperative events that led to development of potentially blinding diseases such as 
glaucoma or endophthalmitis. These were considered failures. Graft problems that were 
amenable to medical or surgical therapy and led to a visual and comfortable eye were counted 
as complications but not as failures. 
 
2.7 Corneal clarity scoring: 
Corneal clarity scoring was assessed at last scheduled visit following the validated CCS scale 
(e.g. a scale shown to have good inter- and intra-observer reproducibility when used to score 
the central corneas of small animals therefore making it apt to assess the outcome of 
surgically managed corneal diseases and to compare outcomes of surgical techniques between 
authors) described by Sanchez et al 1, as summarized below: 
G0: no fundus reflection is visible on retroillumination using a head-mounted indirect 
ophthalmoscope. 
G1: a fundus reflection is visible with retroillumination as described in G0. 
G2: a 0.1 -mm diameter light beam from a handheld slit lamp is visible with the naked eye on 
the anterior surface of the iris and/or lens.  
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G3: gross fundic features are visible when viewed with indirect ophthalmoscopy using a 
head-mounted indirect ophthalmoscope and a handheld 30D lens, although fine details are not 
clear. 
G4: fine details of the fundic features are clearly visible with indirect ophthalmoscopy as 
described in G3. 
2.8 Statistical analysis 
Tests of associations between pre-existing conditions and surgical failure were calculated 
with a Pearson’s Chi Square test of association and a P-value ≤0.05 was considered as 
significant. Correlations between CCS, breed, pre-existing perforation and concurrent medial 
canthoplasty surgery were assessed by Mann-Whitney U Test, and a P-value ≤ 0.05 was 
considered as significant. Comparison of graft position (dorsal, dorsolateral, lateral, 
ventrolateral, ventral, ventromedial, medial and dorsomedial), and comparison of effects of 
medication either as individual medications or grouped as steroidal, non-steroidal anti-
inflammatory or other immunosuppressive were also performed with Mann-Whitney U Test, 
and a P-value ≤ 0.05 was considered as significant. These comparisons were made across the 
entire cohort and also between Pug and non-Pug breeds.  
Wizard 1.9.39 was used for statistical analysis. 
3. RESULTS 
3.1 Animals 
The search yielded 399 medical records comprising a total of 418 surgeries that complied 
with the inclusion criteria. There were 203 right eyes and 213 left eyes and in two cases the 
side of the affected eye was not specified. There were 19 bilateral cases. Brachycephalic 
breeds were most commonly affected accounting for 325/418 (77.75 %) of the eyes affected. 
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Non-brachycephalic breeds accounted for 93/418 (22.25%) of the eyes affected. The most 
common breeds affected were Pugs (116/418, 27.75%), Shih-Tzus (64/418, 15.31%), Cavalier 
King Charles Spaniels (34/418, 8.14%) and French Bulldogs (34/418, 8.14%). (Graph 1). 
There were 249 males (59.57%) and 169 females (40.43%). Mean age at surgery was 5.5 
years (range 59 days – 17.7 years), with a median of 4.8 years. 
 
3.2 Pathogenesis, ulcer description and additional procedures 
The cause of the ulceration was not determined in 205/418 cases, of which 191 (93.17%) 
were brachycephalics. KCS was found in 122/418 eyes (29.19%), injury in 39/418 eyes 
(9.33%) and calcium keratopathy in 19/418 eyes (4.55%). Other causes, such as ectopic 
cilium and entropion, accounted for 33/418 of the eyes (7.89%).   
All the ulcers were centrally or pericentrally located (i.e. affected the visual axis). Mean ulcer 
width was 3.5 mm (0.5-10 mm). Small perforations that were pre-existing or that occurred 
intra-operatively were identified in 101/418 cases (24.16%). Concurrent surgeries were 
performed in 172/418 (41.15%) of the cases, including medial canthoplasty (135/418, 32.3%), 
distichia removal (16/418, 3.83%) (i.e. wedge excision, cryotherapy or electrolysis), entropion 
correction (10/418, 2.39%), eyelid mass resection (8/418, 1.91%), subconjunctival 
cyclosporine implantation (5/418, 1.2%) and ectopic cilium excision (5/418, 1.2%). 
 
3.3 Follow up and outcome 
Median follow up time was 100 days (range 3 days – 7.64 years). Success rate was 97.13% 
(406/418). Failure endpoints recorded included absence of menace response or loss of the 
globe (i.e. enucleation due to severe complications such as endophthalmitis or secondary 
glaucoma). Severe complications that led to the loss of the eye accounted for the short follow 
up times. There were 12/418 (2.87%) failures, leading to enucleation in 11/12 (91.66%) cases 
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and blindness in one eye (1/12 (8.33%). A total of 5/12 (41.67%) were right eyes and 7/12 
(58.33%) were left eyes. Males and females were equally represented, and brachycephalic 
breeds accounted for 7/12 (58.33%). A total of 8/12 (66.67%) eyes had a pre-existing 
perforation at the site of the ulcer, 2/12 (16.67%) had a descemetocele and 2/12 (16.67%) had 
a deep stromal ulcer. A total of 9/12 (75%) of the failures were enucleated due to secondary 
glaucoma or endophthalmitis at a mean time to failure of 24.5 days. The diagnosis of 
endophthalmitis were clinical and later confirmed with histopathology. A total of 2/12 
(16.67%) eyes developed a corneal perforation post-operatively and were enucleated. Neither 
of the 2 eyes presented with a perforation prior to surgery. Lastly, 1/12 (8.33%) eyes lost all 
functional vision after developing graft retraction and excessive scarring.  
There were a total of 32/418 (7.65%) additional post-operative complications that did not fit 
the criteria to be considered failures, bringing the total of complications to 44/418 (10.52%). 
There were four cases that developed corneal perforation post-grafting bringing the total 
count of post-operative perforations to 6/418 (1.43%). These additional 4 cases were treated 
successfully with a second graft. Of these, 3 presented with a perforation prior to surgery. 
Graft retraction occurred in 6/418 (1.43%) cases but all healed successfully, with 5 requiring 
only medical therapy and 1 requiring re-suturing of the graft. A total of 22/418 (5.3%) cases 
developed epithelial inclusion cysts and 2/418 (0.5%) cases developed post-operative 
superficial stromal mineral deposition in the periphery of the corneal graft (i.e. corneal 
degeneration). Two of the 22 (9.09%) cases with epithelial inclusion cyst development were 
considered for surgical removal of the cysts because the cysts were large. One case underwent 
epithelial inclusion cyst excision a year after the initial graft surgery and it resolved without 
problems. The owner of the other patient decided against surgery because there was no 
obvious ocular discomfort and the dog was aggressive and geriatric.  
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Pre-existing perforation, which was found in 24.16% (101/418) of the eyes, significantly 
increased failure rate (i.e. 8 failures compared to 4 for non-perforated eyes) (p<0.001). No 
significant association was found between risk of corneal perforation and age of the patient or 
size of the corneal ulcer at presentation. 
3.4 Corneal clarity score 
Corneal clarity was scored in a total of 111/418 (26.55%) eyes. Brachycephalic breeds were 
also most common in this part of the study as they accounted for 96/111 (86.49%). A total of 
33/111 (29.73%) were Pugs, which made up 33/96 (34.37%) of the brachycephalic patients. 
The overall median CCS was G3 (range G0 to G4) (Fig. 1). Pugs had a median CCS of G2, 
and they were statistically more likely to have a poor CCS compared to all other breeds 
(p=0.002) (Graph 2). Corneal clarity in Pugs was affected by the development pigmentary 
keratitis. There was no statistically significant difference on median CCS between 
brachycephalic and non-brachycephalic groups (p=0.321). The median CCS was lower in 
perforated eyes (G2, p=0.015) compared to non-perforated eyes (G3) (Graph 3). 
The median post-operative follow-up at the time of corneal clarity scoring was 1 year (range 3 
months – 5.8 years). Performing a medial canthoplasty in brachycephalics at the time of 
CLCT did not have an effect on CCS (Graph 4).  
Comparison of the effects of medication (either as individual medications or grouped as 
steroidal, non-steroidal anti-inflammatory or other immunosuppressive) on CCS were made 
across the entire cohort and between Pug and non-Pug breeds, and did not show significant 
correlations (i.e. median CCS of each group was not affected, overall G3 and G2 in Pugs).  
Comparison of graft position (dorsal, dorsolateral, lateral, ventrolateral, ventral, ventromedial, 
medial and dorsomedial) across the entire cohort and between Pug and non-Pug breeds 
showed trends that affected CCS without reaching statistical significance. These included a 
worse CSS in non-Pug breeds on CLCTs that were harvested from the dorsal cornea (median 
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dorsal graft CCS of 3 compared to 4 for other orientations (p=0.06). In Pugs there was less of 
a difference between dorsal and other orientations (median dorsal graft CCS of 1.5 compared 
to 2 for other orientations. (p=0.131)). 
4. DISCUSSION 
There is a relatively low number of clinical studies in the veterinary literature that describe the 
use of autologous lamellar grafting in dogs.6,16–18,26 The first published series on the use of 
CLCT in dogs suggested that further evidence on the outcome of a larger number of cases and 
the use of an objective assessment of corneal clarity were needed.26 The objectives of the 
present study were to report the surgical outcome of a large number of CLCTs in dogs and the 
CCS of a proportion of these cases using the validated scoring system proposed by Sanchez et 
al.1 The results of the present study showed that the CLCT technique is associated with a high 
success rate in dogs and a median CCS that is in the high end of the scale used.  
Some authors recommend autologous corneal lamellar transposition for defects smaller than 
25–30% of the corneal diameter to avoid potentially deficient tectonic support if used to 
reconstruct larger defects and due to the fact there is a limited availability of healthy cornea 
that can be used to treat larger defects.22 In the current study, most CLCTs fell inside this size 
category, though some were larger. Larger CLCTs did not develop more problems than 
smaller ones. However, large CLCTs may mobilize a non-desirable amount of conjunctiva 
into the visual axis, which can negatively affect quality of vision even in cases with a positive 
menace response and an acceptable CCS in the corneal section of the graft. Graft dehiscence 
can occur due to corneal melting, inappropriate graft bed preparation (i.e. insufficient 
conjunctival dissection, unhealthy bed), aqueous humor leakage, excessive tension on the 
graft or sutures, inappropriate suture placement and/or infection of the graft.13 The 
retrospective nature of this study meant that it was not easy to determine the exact cause of 
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each graft failure. Failure was seen in a relatively low number of cases, but it meant 
enucleation could not be completely avoided. In the study by Gogova et al there were no graft 
failures.26 Comparatively speaking, the existence of failures in the present study, though low, 
highlights the importance of analyzing as high a number of cases as possible when studying 
the results of a surgical technique. All of the graft complications reported in this study healed 
following intensive medical management, graft re-suturing or use of a second graft. This is in 
agreement with the Gogova et al study.26 However, the Gogova et al study had a total 
complication rate of 21%26, which was approximately twice as high as the one reported in the 
present study. The study of Gogova et al did not report further on the possible factors that 
might have been associated with the failures observed. However, the higher number of cases 
in the present study might account for a part of this difference. Breed, gender, size of the graft 
and cause of the ulcer did not appear to have a statistically significant association with graft 
failure in the present study, but the existence of a pre-existing perforation did.  
The use of autologous lamellar corneal transposition procedures in dogs have previously been 
described to repair deep corneal ulcers and small corneal perforations.18,20,26,27 However, it 
stands to reason that since there is no endothelium in the transposed section of cornea, 
progressive corneal edema and possible graft dehiscence could result if a graft were used to 
repair a corneal perforation that had also damaged the endothelial layer in that spot. The study 
of Brightman et al (1989) reported finding clear corneas after autologous grafting of full 
thickness defects using a transposition of lamellar cornea that lacked an endothelial cell 
layer.6 The authors described finding endothelial cells with features of polymorphism and 
polymegathism under the graft over time, suggesting an attempt by the endothelium to res-
establish itself.6 In the Gogova et al study just over half the cases were perforations and the 
study did not mention if any of the complications encountered were associated with the 
presence of perforation prior to surgery.26 There were almost twice as many perforations in 
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the present study, which found that CLCT grafting of perforated ulcers had a higher risk of 
graft failure. Therefore, the authors recommend caution when choosing to perform a CLCT to 
treat a perforated ulcer, even if it is a perforation with a small diameter. 
A proportion of failures in the present study were due to the development of endophthalmitis 
and/or secondary glaucoma. Endophthalmitis requires the entrance and settlement of bacterial 
into the eye,30 and it is an obvious potential complication of perforated ulcers. However, 
clinicians need to also consider secondary glaucoma as a potential complication after corneal 
reconstruction with CLCT even in eyes with no obvious pre-existing predisposition to 
glaucoma. Secondary glaucoma is caused through a number of complex pathways including 
chronic inflammation, infection and/or damage to the iridocorneal angle31–33 and, therefore, it 
could be difficult to avoid in some of the patients undergoing CLCT. 
Other complications observed in this study included corneal scarring, corneal degeneration 
and development of epithelial inclusion cysts. However, none of these complications altered 
the subjective appreciation of ocular comfort in any of the patients and did not appear to alter 
the visual outcome in the cases where the problem developed after the cornea had healed.  
It is difficult to pinpoint the exact cause of an epithelial inclusion cyst, but generally speaking 
these cysts are theorized to occur through the forceful introduction of epithelial cells into the 
tissue that lies under the epithelial cover, where the cyst is formed.34 Surgical trauma during 
tissue handling and/or needle trauma during suturing are the most likely causes of the 
epithelial inclusion cysts seen in this study. 
Corneal pigmentation and corneal scarring affect corneal clarity and maintenance of corneal 
clarity should be a primary goal of corneal reconstruction techniques that affect the central 
cornea. Corneal transparency following corneal grafting has previously been evaluated in 
other studies.13,24,26,35–37 However, whenever possible it is advisable that a validated corneal 
clarity scoring system (i.e. one that has been shown to have a high intra- and inter-user 
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variability) is utilized to evaluate corneal clarity, as this tool supports the objective analysis of 
the surgical results and the comparison between techniques and authors.1 The overall median 
corneal clarity score in the present study was high. This appears to be in agreement with the 
results of the Gogova et al study26, although a more balanced comparison of clarity between 
the two studies is not possible.   
It is interesting to note that Pugs in this study had a lower CCS than other breeds. Corneal 
pigmentation is a concern in the breed, with studies showing pigmentary keratitis in the Pug 
affecting anywhere from 70% to up to 91.1% of animals in a variety of populations from the 
US and the EU.38–41 A study published by O’Neil et al in 2017 provided evidence of a strong 
predisposition to corneal ulcerative disease in brachycephalic dogs using an exceptionally 
large, non-referral population.42 The O’Neil et al study also showed that compared to 
crossbred dogs, the Pug, Boxer and Shih Tzu were specifically at risk.42 Not surprisingly, 
brachycephalics, including Pugs, were the most common breeds in the current study. 
Interestingly, though the median CCS in brachycephalics in the present study was high, it was 
significantly lower for Pugs. The reduced corneal clarity in Pugs in the present study was 
associated with the development of pigmentary keratitis. This supports the finding of the 
Gogova et al study that also found pigmentary keratitis to negatively affect corneal clarity.26 
A study that performed in vivo confocal microscopy in affected and unaffected Pugs, reported 
the presence of inflammatory changes in the corneas of Pugs with pigmentary keratitis.40 
Another study found, for the first time, an association between the presence and severity of 
medial entropion of the lower eyelid and the presence of pigmentary keratitis in Pugs.41 This 
supported the theory that the irritation caused by the entropion leads to the pigmentation 
response typically seen in pigmentary keratitis in this breed.41 The study by Gogova et al 
found that patients that had pigmentary keratitis prior to surgery had a more opaque cornea 
than patients that did not have corneal pigmentation.26 Due to the retrospective nature of the 
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present study it was not possible to know with certainty how many patients had pigmentary 
keratitis prior to surgery. The Gogova et al study also found that medial canthoplasty had no 
effect on the degree of corneal opacification in the 8 cases included in that group.26 This is in 
agreement with the findings of the present study that included 10 cases in this category. It is 
possible the low number of animals in this category in each of the studies might have affected 
the results. It is also possible that other factors besides the presence of medial lower eyelid 
entropion played a role in the progression of pigmentary keratitis in Pugs after CLCT. 
Pigmentary keratitis in Pugs has been shown to progress with increasing age.41 However, in 
the comparatively shorter time of the post-operative period it seems likely that the 
development of pigmentary keratitis could partly be due to the irritation caused by the surgery 
and/or the presence of corneal sutures. All the surgeries reported here were performed with 
the same type of absorbable suture material (polyglactin 910, 9-0), which has been shown to 
elicit a foreign body response in the corneas of dogs.43 Absorption of polyglactin is usually 
complete within six weeks43,44 and CCSs in the present study deteriorated rapidly in some 
cases, and especially in Pugs, reaching the worst CCS at the time the sutures had completely 
disappeared (Fig. 2). A study that compared the effects of nylon and Polyglactin 910 on 
perilimbal corneal wound healing in dogs reported that both materials were associated with a 
similar foreign body (e.g. granulomatous) response.43 However, polyglactin sutures used in 
conjunctival surgery of humans resulted in slightly more conjunctival reaction in the early 
postoperative period compared to nylon sutures.45 Interestingly, a study on autologous 
lamellar corneal grafting in dogs determined that although non-absorbable sutures produced 
less corneal vascularization initially, absorbable sutures were associated with less 
vascularization in the longer term because they disappeared once they dissolved compared to 
non-absorbable sutures that were left in place for more than six weeks.6 It is possible that the 
same factors that appear to predispose Pugs to pigmentary keratitis in association with lower 
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medial eyelid entropion,41 and that at least in part appear to be inflammatory,40 could also 
play a role in the reaction to corneal inflammation caused by surgery and absorbable sutures 
compared to other breeds less likely to develop corneal pigmentation. Further studies that 
investigate the type of suture used in CLCT surgeries are needed to improve the CCS of dog 
breeds with predictably lower CCS after surgery, such as Pugs. These studies will need to 
take into account the pre-operative presence or absence of pigmentary keratitis and entropion 
of the medial lower eyelid of the animals included.  
The authors of the present study attempted to identify whether graft orientation had an effect 
on CCS. A trend showing that dorsally harvested CLCTs might have worse CCS was not 
statistically significant. The Gogova et al study found no statistical correlation between 
degree of corneal opacity and graft orientation. Graft orientation could also be part of future 
investigative efforts, though it is possible that an even higher number of cases than in the 
present study might be necessary to further our understanding of this specific aspect of 
CLCTs.  
All the dogs in this study that were diagnosed with KCS were treated with an immune-
modulator/lacrimostimulant drug since before or immediately after surgery and for the long-
term. Overall, cases affected with KCS did not show a significantly different CCS compared 
to the rest of the animals in the study. This is in agreement with the findings of the study by 
Gogova et al that included 40 cases diagnosed with KCS.26 The large number of cases with 
KCS in the present study would have allowed to have non-treated controls. However, no 
untreated cases were included, as their inclusion in a clinical paper could have easily had a 
negative impact on individual patient welfare.   
The limitations in this study are those of a retrospective multicenter study, such as the 
different medical management used pre- and postoperatively in some cases, and the fact that 
re-examination periods were performed at different times due to differences in personal 
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preference and scheduling factors. For instance, this accounted for a wide time range of the 
follow up when the corneal clarity score was granted. Due to the retrospective nature of the 
study it was not possible to know if the length of the follow up time had a positive or negative 
effect on the corneal clarity scoring. A prospective study design could help determine this. 
Moreover, the retrospective nature of the study did not allow the authors to examine the 
effects of pre-existing tissue pigmentation, such as conjunctival, corneal, and/or limbal 
pigmentation, on the postoperative development of pigmentation of the graft. Lastly, there 
were multiple surgeons with different degrees of experience, although every surgeon followed 
the same technique with very small variations.   
5. CONCLUSIONS 
Corneo-limbo-conjunctival transposition is an effective surgical treatment for deep, central 
and paracentral corneal ulcers, as demonstrated through the large number of treated eyes 
included in this study. Although the technique may also be used in small perforations the 
success rate is lower than for non-perforations. In addition, the visual outcome, evaluated for 
the first time using a validated CCS, was good, but it was reduced in Pugs and in cases with 
pre-existing corneal perforation. 
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Graph 1. Distribution of breeds included in the study. 
Graph 2. Comparison between CCS in Pugs (n = 116) versus other breeds (n = 302), showing 
that Pugs have a lower CCS with a median of G2, compared to G3 in the rest of the 
population (Results of Mann-Whitney U Test between “CCS" and Pug vs. others, p value: 
0.002) 
Graph 3. Comparison between CCS in perforated (n = 101) vs. non-perforated eyes (n = 317), 
showing perforated eyes had a lower CCS (Results of Mann-Whitney U Test between CCS 
and perforation vs. non-perforation, p value: 0.015)  
Graph 4. Comparative CCS between brachycephalics having medial canthoplasty surgery (n = 
135) or not (n = 190), showing no statistically significant differences (Results of Mann-
Whitney U Test between CCS and MCP, p value: 0.545) 
 
FIGURE 1. Examples of different surgical outcomes and the CCS assigned to each. 
FIGURE 2. Example of progression of pigment in a case with no pre-existing pigmentary 
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